Get the Stockscreener App
7.62
2.68%
-0.21
Pre-market:
7.63
0.010
+0.13%
Tilray Brands Inc stock is traded at $7.62, with a volume of 2.47M.
It is down -2.68% in the last 24 hours and down -16.99% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mainly from alcohol.
See More
Previous Close:
$7.83
Open:
$7.85
24h Volume:
2.47M
Relative Volume:
0.27
Market Cap:
$887.78M
Revenue:
$829.22M
Net Income/Loss:
$-248.96M
P/E Ratio:
-25.40
EPS:
-0.3
Net Cash Flow:
$-92.10M
1W Performance:
+0.26%
1M Performance:
-16.99%
6M Performance:
-17.17%
1Y Performance:
-18.88%
1-Day Range:
$7.45
$7.88
1-Week Range:
$6.965
$8.305
52-Week Range:
$3.507
$23.20
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
7.62 | 912.25M | 829.22M | -248.96M | -92.10M | -0.30 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-27-26 | Initiated | Canaccord Genuity | Hold |
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Tilray (TLRY) Pharma Expands UK Reach Through Strategic Agreemen - GuruFocus
Tilray Expands UK Pharmaceutical Access Through Strategic Agreement with Smartway Pharmaceuticals - GlobeNewswire
Tilray Brands (NASDAQ:TLRY) Shares Down 2.7%Should You Sell? - MarketBeat
Promising Cannabis Stocks To ConsiderFebruary 11th - MarketBeat
Is Tilray stock going to $0? - MSN
Tilray Brands (NASDAQ:TLRY) Trading Up 1.7%Here's Why - MarketBeat
Promising Cannabis Stocks To Watch TodayFebruary 10th - MarketBeat
Is Tilray Stock Going to $0? - Nasdaq
Tilray Brands (NASDAQ:TLRY) Trading Up 1.6%What's Next? - MarketBeat
Best Cannabis Stocks To ResearchFebruary 9th - MarketBeat
Tilray Shares Blazing: What's Behind the 55% Rally This Month? - MSN
Cannabis Stocks To Keep An Eye OnFebruary 8th - MarketBeat
Tilray Shares Surge on Sector Strength and Strategic Progress - AD HOC NEWS
Cannabis Stocks To ResearchFebruary 7th - MarketBeat
Tilray’s Beverage Division Gains Momentum Amid Cannabis Sector Volatility - AD HOC NEWS
Tilray Builds Medical Cannabis And Spirits Pillars As Share Performance Lags - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Stock Price Up 7.5%Time to Buy? - MarketBeat
Cannabis Stocks To Watch TodayFebruary 6th - MarketBeat
Tilray’s Mixed Quarter: Record Revenue Amid Segment Divergence - AD HOC NEWS
Should You Buy, Hold or Sell ACB Stock Post Q3 Earnings Release? - The Globe and Mail
Tilray Brands (NASDAQ:TLRY) Shares Down 7.2%Time to Sell? - MarketBeat
Best Cannabis Stocks To Keep An Eye OnFebruary 5th - MarketBeat
Tilray Brands (NASDAQ:TLRY) Trading Down 2.3%What's Next? - MarketBeat
Promising Cannabis Stocks To Add to Your WatchlistFebruary 4th - MarketBeat
Stocks in play: Tilray Brands, Inc. - The Globe and Mail
Tilray Brands, Inc. - Baystreet.ca
New distributor brings Breckenridge bourbon and rum to more Illinois shelves - stocktitan.net
CC Pharma Recognized as a TOP 100 Innovator in Germany by Tilray Brands, Inc. - Quiver Quantitative
Tilray’s CC Pharma serves 13,000 German pharmacies, wins TOP 100 award - Stock Titan
Tilray Leverages Craft Beer Portfolio for Major US Sports Weekend - AD HOC NEWS
Tilray Brands (NASDAQ:TLRY) Stock Price Up 4.6%Should You Buy? - MarketBeat
Top Cannabis Stocks To ResearchFebruary 3rd - MarketBeat
Tilray Brands stock has crashed—but a bullish pattern is emerging - TradingView
Tilray Brands Ignites Championship Sunday: Nationwide Tap - GlobeNewswire
Tilray Brands Ignites Championship Sunday: Nationwide Tap Room Events, Big Game Day Deals, and Fan Experiences Announced - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Has Debt But No Earnings; Should You Worry? - 富途牛牛
Cannabis Stocks To Add to Your WatchlistFebruary 2nd - MarketBeat
(TLRY) Technical Patterns and Signals (TLRY:CA) - Stock Traders Daily
Best Cannabis Stocks To Follow TodayJanuary 31st - MarketBeat
Tilray Medical Italia Puts European Cannabis Growth Story To The Test - Yahoo Finance
Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.1%Here's Why - MarketBeat
Is Tilray Brands (TLRY) Offering Opportunity After Prolonged Share Price Declines - Yahoo Finance
A Look At Tilray Brands (TLRY) Valuation As Beverage Initiatives Draw Fresh Attention - Yahoo Finance
TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now? - The Globe and Mail
Tilray Brands (NASDAQ:TLRY) Shares Down 2.9%Time to Sell? - MarketBeat
Tilray’s Q2 2026 Results: A Story of Diverging Segments - AD HOC NEWS
Top Cannabis Stocks To Watch TodayJanuary 29th - MarketBeat
Terrapin Beer Co. Turns Up the Volume with a New Brand Identity Rooted in Music, Art and Craft Beer Culture - Finviz
Tilray (TLRY) Unveils Fresh Branding for Terrapin Beer - GuruFocus
Tilray Shares Navigate Choppy Waters Amid Conflicting Signals - AD HOC NEWS
Tilray Brands (NASDAQ:TLRY) Shares Down 6.8%Here's Why - MarketBeat
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| SIMON IRWIN D | President and CEO |
Jul 31 '25 |
Option Exercise |
0.58 |
706,216 |
409,605 |
5,200,788 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
970,279 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
742,069 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '25 |
Buy |
0.58 |
6,000 |
3,496 |
698,287 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '25 |
Option Exercise |
0.58 |
93,928 |
54,478 |
874,564 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 30 '25 |
Option Exercise |
0.61 |
261,194 |
159,328 |
919,069 |
| Herhalt Johann Michael | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
239,930 |
| Looney Thomas P. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
354,416 |
| Hopkinson David G. | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
335,563 |
| Clanachan David F | Director |
Jul 30 '25 |
Option Exercise |
0.61 |
124,378 |
75,871 |
236,880 |
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):